Skip to Content

Month: February 2022

Deadly US Northwest heat prompts legislation aimed at relief

By SARA CLINE Associated Press/Report for America PORTLAND, Ore. (AP) — Pacific Northwest lawmakers are eyeing several emergency relief bills aimed at helping vulnerable people following last year’s historic heat wave that killed at least 220 people. The measures would provide millions in funding for cooling systems and weather shelters during future extreme weather events.

Continue Reading
From left

Harvard faces Title IX lawsuit after 3 students claim sexual harassment, abuse and retaliation by professor

By Taylor Romine, CNN Three graduate students in Harvard University’s anthropology department are suing the school, claiming it failed to protect students from sexual abuse and career-ending retaliation by a professor, according to a lawsuit filed Tuesday. The plaintiffs, Margaret Czerwienski, Lilia Kilburn and Amulya Mandava, allege that John Comaroff, a professor of African and

Continue Reading
London's Metropolitan Police Service Commissioner Cressida Dick has resigned amid criticism of her leadership following a series of scandals that have dented public confidence in Britain's largest police force.

London Metropolitan Police chief Cressida Dick resigns after series of scandals

By Laura Smith-Spark, CNN London’s Metropolitan Police Service Commissioner Cressida Dick has resigned amid criticism of her leadership following a series of scandals that have dented public confidence in Britain’s largest police force. In a Thursday statement, she said: “It is with huge sadness that following contact with the Mayor of London today, it is

Continue Reading
Famotidine

After hopeful early signs, study of popular heartburn drug shows mixed results against Covid-19

By Elizabeth Cohen, CNN Senior Medical Correspondent At one point at the beginning of the pandemic, there was hope that a popular and inexpensive over-the-counter heartburn drug might hold promise for treating Covid-19, but a newly published study shows mixed results. In the clinical trial, people with mild to moderate Covid-19 who took very high

Continue Reading
Skip to content